HealthCorticosteroid Emflaza Receives FDA Approval As Duchenne Muscular Dystrophy Treatment A new drug approved by the FDA has been shown to delay loss of walking ability for patients diagnosed with Duchenne muscular dystrophy. Emflaza is marketed by Marathon Pharmaceuticals.by Dianne Depra
HealthKaleo Pharmaceuticals Questioned Over 550 Percent Price Hike Of Naloxone Injector Evzio For Opioid Overdoseby Allan Adamson
HealthFalse Alarm Mammograms Can Cause Women To Skip Or Delay Future Breast Cancer Screeningby Allan Adamson
HealthMillions Of Americans Likely Have Hearing Loss Without Knowing It: What Can Be Done?by Katrina Pascual
HealthMake Or Break: How Will Childhood Cancer Treatments Affect Future Sex Lives Of Young Patients?by Arrianne Del Rosario